Study Published Showing Advantages of the PAM50 Gene Signature, the Basis for Prosigna, in Helping to Estimate Risk of Late Distant Recurrence in Postmenopausal Estrogen Receptor Positive Breast Cancer Patients

SEATTLE — NanoString Technologies, Inc., (NASDAQ: NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced that a study published online in the Journal of the National Cancer Institute demonstrated that the PAM50 gene signature, which is the basis for the Prosigna™ Breast Cancer Prognostic Gene Signature Assay, provides [...]

EAGLE – Ibsen launches 822 – 978 nm high resolution spectrometer for Raman solutions

Farum - Ibsen Photonics (www.ibsenphotonics.com), the global leader in fused silica transmission gratings and industrial grade spectrometer modules, today announced the new EAGLE SWNIR spectrometer platform for OEM supply to manufacturers of analytical instruments. The EAGLE platform consists of compact, robust, and high resolution spectrometers, suited for OEM integration into industrial grade Raman systems at [...]

DNAnexus Launches Platform-as-a-Service for Growing NGS-Based Diagnostics Market

MOUNTAIN VIEW, Calif. -- DNAnexus, a pioneer in cloud-based DNA data management and analysis solutions, today announced a specialized platform-as-a-service (PaaS) designed to eliminate the common challenges and costs that enterprises face when building clinically compliant analysis pipelines for next-generation sequencing (NGS) data. DNAnexus provides a configurable API-based platform that enables clinical testing labs to [...]

Quidel Receives Two FDA Clearances for Molecular Diagnostic Tests for Use on Life Technologies QuantStudio(TM) Dx

CARLSBAD, CA and SAN DIEGO, CA -- Quidel Corporation (NASDAQ: QDEL) and Life Technologies Corporation (NASDAQ: LIFE) announced today that the United States Food and Drug Administration (FDA) has granted 510(k) clearances to the Quidel Molecular Influenza A+B assay and the Quidel Molecular RSV + hMPV assay, both for use on the QuantStudio™ Dx Real-Time [...]

DNASTAR Lasergene 11.2 Released Vastly Enhancing Sequence Alignments

MADISON, Wisconsin – DNASTAR® announces the release of Lasergene 11.2 today. As the third release within the Lasergene 11 series this summer, the primary focus for Lasergene 11.2 is to incorporate new sequence alignment methods and tools in the MegAlign Pro application. Lasergene, which has been the most published sequence analysis software in peer reviewed [...]

Alfa Aesar Acquires Biomedical Technologies, Inc.

Heysham, UK -- Alfa Aesar, A Johnson Matthey Company, announces that it has completed the purchase of Biomedical Technologies, Inc. (BTI) of Stoughton, Massachusetts. BTI has been manufacturing life science research products for more than 30 years, with a commitment to its customers of technology, quality and value. Its product line includes specialty proteins, cell [...]

Freeman Technology appoints Product Manager to strengthen support across Central Europe

Tewkesbury, UK: Powder characterisation specialist Freeman Technology has expanded its global team with the appointment of Patrick van Barneveld to the new role of Product Manager for Central Europe. Operating from Almelo, The Netherlands, Patrick will establish a direct company presence in the region to strengthen local support in a number of countries including Austria, [...]

Horizon Discovery Licenses CRISPR Gene-Editing Technology from Harvard University

Cambridge, UK - Horizon Discovery (Horizon), a leading provider of research tools to support translational genomics research and the development of personalized medicines, today announced it has entered into a non-exclusive license agreement with Harvard University to access intellectual property related to the commercialization of CRISPR gene editing technology for research use. By adding CRISPR [...]

Station X Launches New Genomics Software Platform – System will enable cohort-scale genomic analysis

SAN FRANCISCO, CA. –– Station X, Inc. today announced the availability of GenePool®, a secure, cloud-based software application for the management, analysis and communication of genomic and clinical information. Users can perform sophisticated analysis of large data sets of DNA and RNA sequence information and identify relevant biomarkers for personalized medicine. As sequence information becomes [...]

Gentris Corporation Launches Next Generation Human Transcriptome Array

MORRISVILLE, N.C. -- Gentris Corporation (www.gentris.com), a global leader in pharmacogenomics and biorepository solutions, announced today that it is expanding its genomic biomarker offering with the launch of Affymetrix GeneChip(R) Human Transcriptome Array (HTA) services. The GeneChip(R) HTA is a high resolution microarray for gene expression that is designed to empower next-generation expression profiling studies. [...]

Access IBO on Knowledge Center